Stan Smith, Director at MAIA Biotechnology, Inc. (MAIA), bought 938 shares at $3.49 ($3K) on 2023-03-24, disclosed to the SEC on 2023-03-28.
Scheduled purchase ($3k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MAIA | BUY | 2025-12-23 | $140K | — | Filing → |
| MAIA | BUY | 2025-12-09 | $11K | — | Filing → |
| MAIA | BUY | 2025-12-01 | $16K | — | Filing → |